FRA:8GN (Denmark)
Â
Unit (2 Ordinary shares & 3 Wrts)
€
2
(0%)
Aug 3
Business Description
Cessatech AS
ISIN : DK0061411964
Share Class Description:
FRA:8GN: Unit (2 Ordinary shares & 3 Wrts)Total Employee Number:
3Compare
Compare
Traded in other countries / regions
CESSA.Sweden8GN.Germany IPO Date
2021-05-04Description
Cessatech AS is a pharmaceutical company committed to developing and commercializing evidence-based medicines for children for the treatment of paediatric acute pain. The company is advancing a pipeline comprising three assets, all addressing an unmet medical need in the treatment of children. The main candidate, CT001, a fixed-dose nasal spray for treating acute pain in children, is in the pre-launch phase in the U.S. and the EU. CT002, a non-invasive intranasal sedation for children undergoing medical procedures (e.g., MRI scans), has an approved PIP in the EU. CT003, a topical anaesthetic, is currently in pre-clinical development.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.87 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 69.87 | |||||
Beneish M-Score | 0.94 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 30.6 | |||||
3-Year EPS without NRI Growth Rate | 33.7 | |||||
3-Year FCF Growth Rate | 22.5 | |||||
3-Year Book Growth Rate | -27.7 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 22.97 | |||||
9-Day RSI | 29.6 | |||||
14-Day RSI | 35.06 | |||||
3-1 Month Momentum % | 17.79 | |||||
6-1 Month Momentum % | -4.67 | |||||
12-1 Month Momentum % | 79.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 7.42 | |||||
Quick Ratio | 7.42 | |||||
Cash Ratio | 3.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.4 | |||||
Shareholder Yield % | -8.9 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -188.46 | |||||
Net Margin % | -141.3 | |||||
EBITDA Margin % | -188.48 | |||||
FCF Margin % | -216.97 | |||||
OCF Margin % | -216.97 | |||||
ROE % | -89.88 | |||||
ROA % | -68.17 | |||||
ROIC % | -246.5 | |||||
3-Year ROIIC % | 146.88 | |||||
ROC (Joel Greenblatt) % | -398.14 | |||||
ROCE % | -119.89 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 20.56 | |||||
PB Ratio | 18.16 | |||||
Price-to-Tangible-Book | 18.18 | |||||
EV-to-EBIT | -14.33 | |||||
EV-to-EBITDA | -14.33 | |||||
EV-to-Revenue | 26.97 | |||||
EV-to-FCF | -10.56 | |||||
| Price-to-Net-Current-Asset-Value | 18.18 | |||||
| Price-to-Net-Cash | 40 | |||||
Earnings Yield (Greenblatt) % | -6.99 | |||||
FCF Yield % | -7.81 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cessatech AS Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.931 | ||
| EPS (TTM) (€) | -0.072 | ||
| Beta | 0.5133 | ||
| 3-Year Sharpe Ratio | 1.19 | ||
| 3-Year Sortino Ratio | 4.51 | ||
| Volatility % | 59.65 | ||
| 14-Day RSI | 35.06 | ||
| 14-Day ATR (€) | 0.063745 | ||
| 20-Day SMA (€) | 2.168 | ||
| 12-1 Month Momentum % | 79.88 | ||
| 52-Week Range (€) | 1.26 - 3.345 | ||
| Shares Outstanding (Mil) | 18.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cessatech AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cessatech AS Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-26 | In 114 days | ||
| Second quarter earnings results for 2026 | 2026-08-28 | In 24 days | ||
| First quarter earnings results for 2026 | 2026-05-28 | 1.99 (-0.50%) | ||
| General meeting for 2025 | 2026-03-30 09:00 | 2.00 (+0.20%) | ||
| Annual report for 2025 | 2026-02-27 | 2.41 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-27 | 2.41 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-13 | 1.48 (+3.20%) | ||
| Second quarter earnings results for 2025 | 2025-08-21 | 1.50 (+1.76%) | ||
| First quarter earnings results for 2025 | 2025-05-15 | 1.78 (-0.34%) | ||
| General meeting for 2024 | 2025-03-28 09:00 | 1.09 (-2.25%) |
Show
Entries
Cessatech AS Frequently Asked Questions
What is Cessatech AS(FRA:8GN)'s stock price today?
The current price of FRA:8GN is €2.00. The 52 week high of FRA:8GN is €3.35 and 52 week low is €1.26.
When is next earnings date of Cessatech AS(FRA:8GN)?
The next earnings date of Cessatech AS(FRA:8GN) is 2026-08-28.
Does Cessatech AS(FRA:8GN) pay dividends? If so, how much?
Cessatech AS(FRA:8GN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Cessatech AS
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers